Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ncoa5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NCOA5 mRNA | CTD | PMID:36331819 | Ncoa5 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NCOA5 mRNA | CTD | PMID:22206623 | Ncoa5 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:19095052 | Ncoa5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NCOA5 mRNA | CTD | PMID:21570461 | Ncoa5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NCOA5 mRNA | CTD | PMID:22574217 | Ncoa5 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of NCOA5 mRNA | CTD | PMID:21346803 | Ncoa5 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NCOA5 mRNA | CTD | PMID:36041667 | Ncoa5 | Rat | aflatoxin B1 | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of NCOA5 mRNA | CTD | PMID:19770486 | Ncoa5 | Rat | aristolochic acid A | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of NCOA5 mRNA | CTD | PMID:33212167 | Ncoa5 | Rat | arsenite(3-) | multiple interactions | ISO | NCOA5 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to NCOA5 mRNA] | CTD | PMID:32406909 | Ncoa5 | Rat | atrazine | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of NCOA5 mRNA | CTD | PMID:22378314 | Ncoa5 | Rat | avobenzone | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | avobenzone results in decreased expression of NCOA5 mRNA | CTD | PMID:31016361 | Ncoa5 | Rat | benzo[a]pyrene | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of NCOA5 mRNA | CTD | PMID:22228805 | Ncoa5 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20382639 | Ncoa5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NCOA5 mRNA | CTD | PMID:25181051 and PMID:34947998 | Ncoa5 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NCOA5 mRNA | CTD | PMID:36041667 | Ncoa5 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NCOA5 mRNA | CTD | PMID:36041667 | Ncoa5 | Rat | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of NCOA5 protein | CTD | PMID:28903499 | Ncoa5 | Rat | caffeine | affects phosphorylation | ISO | NCOA5 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of NCOA5 protein | CTD | PMID:35688186 | Ncoa5 | Rat | chlorpyrifos | decreases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of NCOA5 mRNA | CTD | PMID:37019170 | Ncoa5 | Rat | choline | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NCOA5 gene | CTD | PMID:20938992 | Ncoa5 | Rat | coumarin | affects phosphorylation | ISO | NCOA5 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of NCOA5 protein | CTD | PMID:35688186 | Ncoa5 | Rat | cyclosporin A | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of NCOA5 mRNA | CTD | PMID:25562108 | Ncoa5 | Rat | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of NCOA5 mRNA | CTD | PMID:23640034 | Ncoa5 | Rat | Dibutyl phosphate | affects expression | ISO | NCOA5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of NCOA5 mRNA | CTD | PMID:37042841 | Ncoa5 | Rat | dioxygen | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of NCOA5 mRNA | CTD | PMID:24236059 | Ncoa5 | Rat | doxorubicin | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of NCOA5 mRNA | CTD | PMID:29803840 | Ncoa5 | Rat | enzyme inhibitor | multiple interactions | ISO | NCOA5 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NCOA5 protein | CTD | PMID:23301498 | Ncoa5 | Rat | epoxiconazole | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of NCOA5 mRNA | CTD | PMID:35436446 | Ncoa5 | Rat | ethanol | affects expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Ethanol affects the expression of NCOA5 mRNA | CTD | PMID:30319688 | Ncoa5 | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of NCOA5 mRNA | CTD | PMID:34044035 | Ncoa5 | Rat | folic acid | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NCOA5 gene | CTD | PMID:20938992 | Ncoa5 | Rat | FR900359 | increases phosphorylation | ISO | NCOA5 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of NCOA5 protein | CTD | PMID:37730182 | Ncoa5 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of NCOA5 mRNA | CTD | PMID:33387578 | Ncoa5 | Rat | inulin | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NCOA5 mRNA | CTD | PMID:36331819 | Ncoa5 | Rat | iron dichloride | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of NCOA5 mRNA | CTD | PMID:35984750 | Ncoa5 | Rat | ivermectin | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of NCOA5 protein | CTD | PMID:32959892 | Ncoa5 | Rat | L-methionine | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NCOA5 gene | CTD | PMID:20938992 | Ncoa5 | Rat | lead(0) | affects expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Lead affects the expression of NCOA5 mRNA | CTD | PMID:28903495 | Ncoa5 | Rat | leflunomide | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of NCOA5 mRNA | CTD | PMID:28988120 | Ncoa5 | Rat | methotrexate | affects expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Methotrexate affects the expression of NCOA5 mRNA | CTD | PMID:18502557 | Ncoa5 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of NCOA5 gene | CTD | PMID:35440735 | Ncoa5 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of NCOA5 mRNA | CTD | PMID:24810058 | Ncoa5 | Rat | niclosamide | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of NCOA5 mRNA | CTD | PMID:36318118 | Ncoa5 | Rat | paracetamol | affects expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NCOA5 mRNA | CTD | PMID:17562736 | Ncoa5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NCOA5 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NCOA5 mRNA | CTD | PMID:36331819 | Ncoa5 | Rat | perfluorooctanoic acid | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of NCOA5 protein | CTD | PMID:26879310 | Ncoa5 | Rat | pirinixic acid | multiple interactions | ISO | Ncoa5 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NCOA5 mRNA | CTD | PMID:19710929 | Ncoa5 | Rat | resveratrol | decreases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | resveratrol results in decreased expression of NCOA5 protein | CTD | PMID:25505154 | Ncoa5 | Rat | rotenone | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of NCOA5 mRNA | CTD | PMID:29955902 | Ncoa5 | Rat | SB 431542 | multiple interactions | ISO | NCOA5 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NCOA5 protein | CTD | PMID:37664457 | Ncoa5 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of NCOA5 mRNA | CTD | PMID:34492290 | Ncoa5 | Rat | tremolite asbestos | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | tremolite results in increased expression of NCOA5 mRNA | CTD | PMID:29279043 | Ncoa5 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of NCOA5 mRNA | CTD | PMID:33387578 | Ncoa5 | Rat | triphenyl phosphate | affects expression | ISO | NCOA5 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of NCOA5 mRNA | CTD | PMID:37042841 | Ncoa5 | Rat | tunicamycin | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of NCOA5 mRNA | CTD | PMID:17127020 | Ncoa5 | Rat | valproic acid | decreases methylation | ISO | NCOA5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of NCOA5 gene | CTD | PMID:29154799 | Ncoa5 | Rat | valproic acid | increases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of NCOA5 mRNA | CTD | PMID:21427059 | Ncoa5 | Rat | valproic acid | affects expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of NCOA5 mRNA | CTD | PMID:17292431 | Ncoa5 | Rat | valproic acid | decreases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NCOA5 mRNA | CTD | PMID:19101580 and PMID:29154799 | Ncoa5 | Rat | valproic acid | decreases expression | ISO | Ncoa5 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of NCOA5 mRNA | CTD | PMID:20546886 and PMID:21427059 | Ncoa5 | Rat | valproic acid | increases expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NCOA5 mRNA | CTD | PMID:23179753 | Ncoa5 | Rat | valproic acid | affects expression | ISO | NCOA5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NCOA5 mRNA | CTD | PMID:25979313 | |